Open access pricing

[brs4@lehigh.edu]

(cross-posted)

Regarding the statement below, the following thought of course occurs to
many, so it might as well be made explicit for discussion. If Elsevier
moves into the open access arena, will this pressure commercial
enterprises such as the BioMed Centrals of the world to raise *their*
prices, just to survive?

Brian Simboli

===

"Where innovations bring demonstrable and sustainable improvements for
these communities, Elsevier will, as always, adapt and invest
accordingly".